Medscint at ASTRO 2026 in Boston | HYPERSCINT® QA

Medscint team at ASTRO 2026 Annual Meeting in Boston presenting scintillation dosimetry solutions

Medscint at ASTRO 2026 in Boston

Medscint is excited to announce its participation in the ASTRO 2026 Annual Meeting, ASTRO’s 68th Annual Meeting, taking place September 26 to September 30, 2026 in Boston, MA. This premier global event brings together radiation oncology professionals, clinicians, researchers, and industry leaders to share groundbreaking science and shape the future of cancer care.

Introducing HYPERSCINT® QA – Our Clinical Dosimetry Solution

Now available to medical physics teams, the HYPERSCINT® QA is our next-generation clinical solution for quality assurance in radiotherapy. This medical device leverages Medscint’s unique hyperspectral plastic scintillator technology to simplify and enhance QA workflows. With HYPERSCINT® QA you:

  • Gain confidence in your 𖦏 small field dosimetry
  • Simplify your End-to-End QA 🛠 workflows
  • Leverage scintillator’s unique and versatile multi-point capability
Versatile, non-perturbing, and easy to use, HYPERSCINT® QA is a unique asset in the clinical physicist’s toolbox; from small fields and non-standard fields dosimetry to end-to-end QA of SRS and radiosurgery plans, whether targeting single or multiple lesions simultaneously.

Meet Our Team at Booth #1436

We warmly invite you to connect with our scintillation dosimetry experts on-site on the exhibition floor on September 27, 28 and 29, 2026. Discover how scintillation dosimetry is shaping the future of radiation oncology and explore how HYPERSCINT® QA can bring value to your practice.

👉 Book a meeting in advance with our team to secure your spot and experience a live demo.

See you in BOSTON!

For more details and registration info on the conference, visit ASTRO 2026